Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Low-toxicity antitumor agents described by Ajinomoto

Nov. 1, 1996

Antitumor organotin compounds claimed by Dutch company

Nov. 1, 1996

Peregrine seeks partners for development of vascular targeting agents

Nov. 1, 1996

Cell adhesion inhibitors reported by Sumitomo

Nov. 1, 1996

PDL signs humanized antibody agreement with Japanese company

Nov. 1, 1996

First gene gun clinical trial announced by Auragen

Nov. 1, 1996

HHS claims MAb for therapeutic, diagnostic and immunologic applications

Nov. 1, 1996

Antitumor antibody for medulloblastoma Rx claimed by Chugai

Nov. 1, 1996

Taxotere now approved in 35 countries

Nov. 1, 1996

Polyamine antimetabolites claimed by Ciba-Geigy

Nov. 1, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...